Literature DB >> 3704568

Bladder training and terodiline in females with idiopathic urge incontinence and stable detrusor function.

P Klarskov, T C Gerstenberg, T Hald.   

Abstract

Twenty consecutive female patients with urge incontinence and stable detrusor function on provocative rapid fill CO2-cystometry were treated as out-patients with a bladder training programme and with terodiline/placebo in a double-blind cross-over design. Frequency and incontinence episodes decreased significantly, while first sensation and cystometric bladder capacity increased. Both objectively and subjectively terodiline was significantly better than placebo with 50% (95% confidence limits 18-82) more patients improved on terodiline than on placebo. Thirty percent of the patients (95% confidence limits 12-54) relapsed after withdrawal of terodiline. At 3 months follow-up the remaining 70% were satisfied with the outcome of the training programme. Side effects were mild and reversible. Serum creatinine and alkaline phosphatase increased slightly on terodiline and the diastolic blood pressure was probably also increased by terodiline. In conclusion, female patients with idiopathic urge incontinence and stable detrusor function did respond to treatment as do female patients with urge incontinence and proven instability.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3704568     DOI: 10.3109/00365598609024478

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  6 in total

1.  A calcium blocking and anticholinergic agent (terodiline) in the treatment of detrusor hyperreflexia: a placebo-controlled, cross-over trial.

Authors:  T Petersen; J Jakobsen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-10       Impact factor: 10.154

Review 2.  Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults.

Authors:  Bhavan Prasad Rai; June D Cody; Ammar Alhasso; Laurence Stewart
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

Review 3.  Terodiline. A review of its pharmacological properties, and therapeutic use in the treatment of urinary incontinence.

Authors:  H D Langtry; D McTavish
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

4.  Terodiline in the treatment of nocturnal enuresis in children.

Authors:  M Ishigooka; T Hashimoto; I Sasagawa; K Izumiya; T Nakada
Journal:  Int Urol Nephrol       Date:  1992       Impact factor: 2.370

5.  Tolerability and steady-state pharmacokinetics of terodiline and its main metabolites in elderly patients with urinary incontinence.

Authors:  B Hallén; S Bogentoft; S Sandquist; S Strömberg; G Setterberg; E Ryd-Kjellén
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

6.  Adult urinary incontinence: Assessment, intervention, and the role of clinical health psychology in program development.

Authors:  S M Tovian; R H Rozensky; T B Sloan; G M Slotnick
Journal:  J Clin Psychol Med Settings       Date:  1994-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.